Viewing Study NCT02955550


Ignite Creation Date: 2025-12-24 @ 5:01 PM
Ignite Modification Date: 2026-01-04 @ 7:05 AM
Study NCT ID: NCT02955550
Status: COMPLETED
Last Update Posted: 2020-07-22
First Post: 2016-11-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Safety Study of Human Cord Blood Derived, Culture-expanded, Natural Killer Cell (PNK-007) Infusion With or Without Subcutaneous Recombinant Human Interleukin-2 (rhIL-2) Following Autologous Stem Cell Transplant for Multiple Myeloma (MM)
Sponsor: Celularity Incorporated
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module